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Background: Monocytes reportedly contribute to liver regeneration. Three subsets have been identified to date:
classical, intermediate, non-classical monocytes. The intermediate population and a subtype expressing TIE2 (TEMs)
were suggested to promote angiogenesis. In a clinical setting, we investigated which monocyte subsets are
regulated after liver resection and correlate with postoperative liver function.
Methods: In 38 patients monocyte subsets were evaluated in blood and subhepatic wound fluid by flow cytometry
before and 1-3 days after resection of colorectal liver metastases. The monocyte-regulating cytokines macrophage
colony stimulating factor (M-CSF), transforming growth factor beta 1 (TGFβ1), and angiopoietin 2 (ANG-2) were
measured in patient plasma by ELISA. C-reactive protein (CRP) and liver function parameters were retrieved from
routine hospital analyses.
Results: On post-operative day (POD) 1 blood monocytes shifted to significantly elevated levels of intermediate
monocytes. In wound fluid, a delayed surge in intermediate monocytes was detected by POD 3. Furthermore, TEMs
were highly enriched in wound fluid as compared to circulation. CRP and M-CSF levels were substantially increased
in patient blood after surgery and correlated significantly with the frequency of intermediate monocytes. In
addition, liver function parameters showed a significant association with intermediate monocyte levels on POD 3.
Conclusions: The reportedly pro-angiogenic subsets of monocytes are selectively increased upon liver resection
and accumulate next to the site of liver regeneration. As previously proposed by in vitro experiments, the release
of CRP and M-CSF may trigger the induction of intermediate monocytes. The correlation with liver parameters
points to a functional involvement of these monocyte populations in liver regeneration which warrants further
investigation.
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Liver resection or ablation remains the only potentially
curative option for patients with colorectal liver metastases
to date. Factors determining the risk of post-operative com-
plications which may occur in 40-50% of patients have been
investigated extensively [1-3]. Generally, morbidity is re-
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unless otherwise stated.and thus fulfil its metabolic functions [4]. Monocytes as
central players of the immune system play a pivotal role in
liver regeneration. While overall numbers of monocytes in-
crease after surgery, their immune function is partly sup-
pressed [5,6]. Of note, a two-fold increase in monocytes on
the first post-operative day has been found predictive in
terms of enhanced overall survival after resection of colo-
rectal liver metastases [7].
The complex regulation of monocytes involves an array
of proteins including C-reactive protein (CRP), macro-
phage colony stimulating factor (M-CSF), transforming
growth factor beta 1 (TGFβ1) and angiopoietin 2 (ANG-2)l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ment and differentiation of monocyte populations for
functional responses in phagocytosis, antigen presentation,
angiogenesis and cytokine release. Furthermore, mono-
cytes that migrate into the tissue develop into macro-
phages and dendritic cells which shape the local immune
response and tissue regeneration [11-13]. The importance
of M-CSF and monocyte-derived macrophages in liver
regeneration has been investigated in mice genetically
lacking functional M-CSF [11]. These mice showed a re-
duction of Kupffer cells in the liver by 60%. After partial
hepatectomy the mice exhibited a significantly reduced
proliferation of hepatocytes and a delayed hepatic regener-
ation. Treatment with recombinant M-CSF resulted in the
recovery of Kupffer cell counts and liver regeneration.
An indication as to how M-CSF is induced upon liver
damage came from the in vitro observation that the
acute phase protein CRP may stimulate endothelial cells
and macrophages to secrete M-CSF [14]. M-CSF is known
to function as a chemoattractant for monocytes to in-
flamed or injured tissues [15] and can further promote
survival and differentiation of monocytes [16,17]. Thus, it
was shown that cytokines such as M-CSF and TGFβ1 trig-
ger a phenotypic shift of circulating human monocytes by
inducing the expression of CD16, the low-affinity im-
munoglobulin G receptor involved in antibody-dependent
cellular cytotoxicity [8,10].
By differential expression of their receptors CD16 and
CD14, the co-receptor for lipopolysaccharide (LPS), hu-
man monocytes are classified as CD14++CD16- “classical
monocytes”, CD14++CD16+ “intermediate monocytes”
and CD14+CD16++ “non-classical monocytes” [18]. Func-
tional and genetic studies have indicated a developmental
relationship between these subsets with gradual changes
in surface markers during maturation as well as distinct
biological properties [19,20]. Classical monocytes which
amount to 85% of circulating monocytes, show the highest
phagocytosis potential and are potent producers of pro-
inflammatory cytokines in response to the bacterial com-
ponent LPS [19,20]. In contrast, non-classical monocytes,
amounting to 10% of total monocytes, exhibit a “patrol-
ling” (crawling) behaviour along vessel walls and react
strongly against viruses [21,22]. Intermediate monocytes
have been linked to antigen presentation as well as angio-
genesis [20]. Thus, factors involved in MHCII complex
formation (HLA-DR and CD74) and angiogenic molecules
such as TIE2, endoglin and VEGFR2 (vascular endothelial
growth factor receptor 2) are expressed at highest levels in
the intermediate subset and point to functions in tissue re-
modelling [9,20].
A rare subset of monocytes is known to express TIE2,
the receptor for angiopoietins, and is therefore termed
TIE2 expressing monocytes (TEMs) [23]. With respect to
the official classification of monocytes, TIE2 expression ispredominantly but not exclusively detected on intermedi-
ate monocytes [9,20]. TEMs were found to migrate to an-
giogenic sites in tumours potentially involving chemotaxis
in response to ANG-2 [23,24]. They may stimulate angio-
genesis by the paracrine secretion of growth factors such
as VEGF and basic fibroblast growth factor [24].
While the majority of functional studies have been con-
ducted in mouse models, substantial evidence has addition-
ally been gathered in the human setting demonstrating that
human intermediate monocytes and TEMs carry angio-
genic markers and have angiogenic properties [9,20,25].
Thus, endothelial cell sprouting and tube formation were
more potently induced by human TEMs than by TIE2-
negative monocytes [25], and intermediate as opposed to
classical and non-classical monocytes were described as the
subset with distinct tube forming capability [20].
In contrast to studies performed on cancer patients, lit-
tle is known about the regulation and contribution of pro-
angiogenic monocyte subsets in the context of clinical
liver resection and regeneration. Since surgery triggers
the release of CRP from the liver and as a consequence
may raise the levels of circulating M-CSF, a shift in mono-
cytes towards CD16 positive subsets and their functional
properties is conceivable. Given the pro-angiogenic poten-
tial of CD16+ intermediate monocytes and TEMs, we
hypothesized that they are induced by liver surgery and
subsequently localize at the resection site to promote tis-
sue regeneration. Conversely, failure of the immune sys-
tem to recruit the reportedly pro-angiogenic TEMs and
intermediate monocytes might result in adverse outcome
after surgery.
To address this subject, we conducted a study on 38 pa-
tients undergoing resection of colorectal liver metastases.
We examined postoperative changes in the monocyte pro-
file of patient blood as well as in wound fluid of subhepatic
drainages. Alterations in monocyte subsets were investi-
gated for a potential correlation with circulating levels
of monocyte regulating cytokines including CRP, M-CSF,
TGFβ1 and ANG-2. Furthermore, monocyte populations
and related cytokines were assessed for a potential associ-




We analysed a total of 38 patients with liver metastases
from colorectal cancer undergoing hepatic resection at
the Department of Surgery, Medical University of Vienna
between 2007 and 2011. Prior to liver surgery all patients
underwent chemotherapy with a standard combination,
mostly including bevacizumab. The majority of patients
had their primary tumour resected before diagnosis
and treatment of metastases. Patients with pre-existing
liver disease were excluded from the study. The patient
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function and type of hepatic resection are summarized
in Table 1. Liver resections were classified in minor (≤3
segments) and major (>3 segments) hepatectomy. Com-
parably, a sex- and age-matched control collective of 32
healthy individuals was included in the study. Analyses
of patient samples were approved by the Institutional
Ethics Committee (#300/2006, #437/2006, #791/2010).
All patients gave written informed consent.
Sample collection
Blood was drawn before surgery (pre-OP) prior to the pa-
tients’ transfer to the operating room and on post-operative
day (POD) 1 and 3. Furthermore, in a subset of 12 patients
wound fluid was additionally collected on POD 1 and POD
3. Surgical drainage catheters were placed intraabdominally
directly subhepatic, to collect subhepatic wound exudate
(SHW) close to the site of liver regeneration.
Analysis of monocyte populations
Blood was drawn into EDTA (ethylenediamine tetraacetic
acid) containing tubes and processed at room temperature.
Surface expression of CD14, CD16 and TIE2 was mea-
sured applying direct immunofluorescence staining followed
by a lyse-no-wash procedure. In brief, 100 μl of whole
blood were incubated with the following antibodies at
saturating concentrations for 20 minutes: CD14-FITC
(Becton-Dickinson, San Jose, CA, USA), CD16-PC5 (Beckman





Site of primary tumour
Colon 23 (61%)
Rectum 15 (39%)
Concomitant primary resection 7 (18%)
Type of hepatic resection
Major 20 (53%)
Minor 18 (47%)
Preoperative parameters of liver function Median (Range)
Bilirubin (mg/dl) 0.64 (0.35-1.71)
ALAT (U/l) 22 (9–346)
ASAT (U/l) 28 (8–404)
gGT (U/l) 35 (13–266)
PT (%) 107 (45–135)
Age (years) 65 (42–80)
gGT: gamma-glutamyltransferase, ALAT: alanine aminotransferase, ASAT: aspartate
aminotransferase, PT: prothrombin time.Inc., Minneapolis, MN, USA). To eliminate erythrocytes
the Versa Lyse solution (Beckman Coulter) was added for
20 minutes. Wound exudate was aspirated from drainage
bags and transferred into an EDTA containing tube to
allow for a comparable mode of sample processing and
immunostaining as described for blood samples.
Flow cytometry was immediately performed with an
FC500 cytometer (Beckman Coulter). Fluorescence gating
parameters were established using antibody isotype con-
trols, and values above the 99% negative staining threshold
were considered positive. A total of 300.000 leukocytes
were measured. Analysis of flow cytometry data was per-
formed with Kaluza software (Beckman Coulter) and the
gating strategy is documented in the Additional file 1.
Intermediate monocytes (CD14++CD16+) were identified
by high-level expression of CD14 and were further distin-
guished from classical monocytes (CD14++CD16-) by their
co-expression of CD16. Numbers of intermediate and clas-
sical monocytes were combined to yield the total CD14++
monocyte count. TEMs were identified by the concomitant
expression of CD14 and TIE2 (CD14++TIE2+ cells). Data
are given in % frequency of total CD14++ monocytes.
Analysis of soluble blood parameters
For plasma preparation, blood was drawn into pre-chilled
tubes containing CTAD (citrate, theophylline, adenosine
and dipyridamole) and was processed on ice within 30 mi-
nutes as we have previously described [26]. Plasma sam-
ples were stored in aliquots at −80°C until further analysis.
For measurement of ANG-2, M-CSF (R&D Systems, Inc.,
Minneapolis, MN, USA) and TGFβ1 (eBioscience, San
Diego, CA, USA) commercially available ELISA kits were
applied according to the manufacturers’ instructions. As
the levels of active, unbound TGFβ1 were below the de-
tection limit in CTAD plasma, total TGFβ1 was measured
after acid-activation of plasma samples according to the
manufacturer’s protocol. Thus, TGFβ1 values are given as
the concentration of total protein including both, the ac-
tive, freely circulating and the inactive, latency-associated
peptide bound form of TGFβ1. Serum CRP levels and pa-
rameters of liver function or injury were available from
routine hospital evaluation.
Statistical analysis
Statistical calculations were based on non-parametric tests
using SPSS software version 20 (SPSS Inc., Chicago, IL,
USA). Due to the challenges in collecting samples in a clin-
ical setting, the available number of measured parameters
varied with time points. Please note that statistical tests for
paired samples were conducted, i.e., differences between
time points were calculated using the Wilcoxon Test.
Correlations between the investigated parameters were
determined by Spearman’s rank correlation coefficient.
The reported p-values were results of two-sided tests.
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the study design was explorative, no corrections for mul-
tiple testing were performed.
Results
Liver resection triggers an increase in intermediate
monocytes in patient blood
We applied triple immunostaining and flow cytometry
to determine the frequency of monocyte populations in
human blood. When patients prior to surgery were com-
pared to a sex-matched (18 male, 14 female) and age-
matched (median age 56, range 42–74) control collective
of 32 healthy individuals, the distribution of monocyte
subsets did not differ significantly (Additional file 2).
Perioperative changes of monocyte subsets were then
monitored in our collective of patients who underwent
surgery for colorectal liver metastases. When determin-
ing total CD14++ monocytes in % of all leukocytes, there
was no significant change within the first 24 hours and
only a moderate increase (p = 0.022, N = 17) on post-
operative day 3 (Figure 1A). However, when we evalu-
ated the distribution of classical (CD14++CD16-) and
intermediate (CD14++CD16+) subsets within the mono-
cyte population (Figure 1B/C), we found a pronounced
decrease in the classical and a substantial increase in
the intermediate compartment on POD 1 (p < 0.001,
N = 24). While intermediate monocytes ranged at 6%
pre-OP, median levels were elevated to 16% after sur-
gery. From POD 1 to POD 3, this trend was reversedFigure 1 Perioperative changes in circulating monocyte populations.
retrieved from patients undergoing liver resection for colorectal liver metastas
the distribution of classical CD14++CD16- monocytes (B), intermediate CD14+
(Pre-OP) and on post-operative days 1 (POD 1) and 3 (POD 3).(p = 0.019, N = 21) indicating a phase of recovery; but
subset distribution did not reach preoperative values
(p = 0.006, N = 17). With respect to circulating TIE2 ex-
pressing monocytes (CD14++TIE2+), we did not record
any surgery-induced alterations (Figure 1D).
Intermediate monocytes display a delayed increase in
wound fluid compared to blood
When evaluating monocytes at the wound site, we found
a moderate accumulation of total CD14++ monocytes
from POD 1 to POD 3 (Figure 2A; p = 0.028, N = 10).
Classical monocytes were the predominant fraction
(98%) in wound exudate on POD 1 (Figure 2B), while
median levels of intermediate monocytes rose to 20% by
POD 3 (Figure 2C; p = 0.005, N = 10). The percentage of
TIE2+ cells within CD14++ monocytes remained con-
stant in wound fluid during the post-operative observa-
tion period (Figure 2D).
TIE2+ monocytes are enriched at the wound site
To evaluate the distribution of monocytes in circulation
as opposed to the area close to liver regeneration,
we compared the frequency of monocyte subsets
in blood and subhepatic wound exudate collected by
surgical drainages. Monocytes within total leukocytes
(Figure 3A) were less abundant in wound fluid (1.8%) as
compared to blood (9.4%) on POD 1 (p = 0.003, N = 11)
and increased to 5.1% in wound exudate by POD 3.
While peak levels of intermediate monocytes in bloodMonocyte subsets were determined by flow cytometry in blood samples
es. The frequency of total CD14++ monocytes (A) was compared to
+CD16+ monocytes (C), and CD14++TIE2+ TEMs (D) prior to surgery
Figure 2 Distribution of monocyte subsets in subhepatic wound fluid. Subhepatic wound fluid was collected on POD 1 and POD 3, and
the following monocyte subsets were evaluated by flow cytometry: (A) total CD14++ monocytes, (B) classical CD14++CD16- monocytes,
(C) intermediate CD14++CD16+ monocytes, and (D) CD14++TIE2+ TEMs.
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the highest value of intermediate monocytes was re-
corded on POD 3 at the wound site (20.4% of CD14++
cells). Of interest, the fraction of TIE2+ cells was sub-
stantially higher for wound than for blood monocytesFigure 3 Comparison of monocyte distribution in blood and wound f
detected by immunostaining and flow cytometry on POD 1 and POD 3 and w
monocytes and the distribution of classical CD14++CD16- monocytes (B), inte(Figure 3D). While the reportedly pro-angiogenic sub-
set of CD14++TIE2+ cells ranged at 6.1% of all CD14++
monocytes in circulation, values reached 35.4% of
TIE2 expressing monocytes in post-operative SHW
(p = 0.003, N = 11).luid. Monocytes in blood and subhepatic wound fluid (SHW) were
ere compared with respect to (A) the frequency of total CD14++
rmediate CD14++CD16+ monocytes (C), and CD14++TIE2+ TEMs (D).
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regulating cytokines
To identify cytokines that might potentially be involved
in regulating the rapid changes of blood monocyte sub-
sets observed on the first day after surgery, we deter-
mined the plasma concentrations of M-CSF, TGFβ1,
ANG-2 and CRP. We found that median levels of
M-CSF (Figure 4A) were more than doubled on POD 1
compared to pre-operative values (p < 0.001, N = 19).
Similarly, a significant induction was recorded for total
TGFβ1 (Figure 4B; p = 0.011, N = 18) and ANG-2 levels
(Figure 4C; p < 0.001, N = 29) on POD 1. Among the
investigated blood components, serum CRP levels showed
the highest increase (15-fold) on POD 1 (Figure 4D;
p < 0.001, N = 35).Blood levels of intermediate monocytes correlate with
plasma values of M-CSF and CRP
A potential association between the induction of inter-
mediate monocytes and the investigated plasma parame-
ters was subsequently evaluated by Spearman correlation
test. CRP blood concentrations correlated positively with
M-CSF levels (Figure 5A; Rho = 0.813, p < 0.001, N = 37).
For both, CRP (Figure 5C; Rho = 0.620, p < 0.001, N = 52)
and M-CSF (Figure 5B; Rho = 0.724, p < 0.001, N = 35) a
strong correlation was observed with intermediate mono-
cytes of CD14++ cells, whereas TGFβ1 showed only a
weak association with CRP values (Figure 5D; Rho = 0.358,
p = 0.032, N = 36) and the frequency of intermediateFigure 4 Perioperative changes in the blood levels of monocyte-regu
by ELISA in plasma samples of patients before (Pre-OP) and after liver surge
routine hospital analyses.monocytes (Figure 5E; Rho = 0.439, p = 0.009, N = 34). No
significant correlation was detected between TIE2 express-
ing monocytes and the potentially regulating cytokine
ANG-2 (Figure 5F).Intermediate monocytes on POD 3 correlate with liver
function parameters
To evaluate if altered monocyte distributions after surgery
were associated with liver regeneration, clinical parameters
of liver function and injury were acquired from routine
hospital tests. No correlation was found between inter-
mediate monocytes and liver parameters before surgery
or on post-operative day 1. However, significant positive
correlations were recorded for the frequency of intermedi-
ate monocytes on POD 3 and bilirubin (Figure 6A; Rho =
0.613, p = 0.009, N = 17), aspartate aminotransferase ASAT
(Figure 6B; Rho = 0.553, p = 0.026, N = 16), alanine amino-
transferase ALAT (Figure 6C; Rho = 0.524, p = 0.037,
N = 16), and the cell destruction marker lactate dehydro-
genase LDH (Figure 6D; Rho = 0.577, p = 0.019, N = 16) on
POD 3–4. Please note that liver parameters on POD 4 were
included in case of missing values for POD 3 to increase
sample size.
Histological parameters of the resected liver tissue were
additionally evaluated (Table 2) to assess whether liver
pathologies might be associated with liver function (regen-
eration) and the intermediate monocyte subset. Neither the
stage of fibrosis nor the percentage of steatosis correlated
with liver function parameters or intermediate monocyteslating cytokines. M-CSF (A), TGFβ1 (B), and ANG-2 (C) were measured
ry (POD 1). Serum concentrations of CRP (D) were retrieved from
Figure 5 Correlations between monocyte-regulating cytokines and the intermediate monocyte subset. Blood levels of CRP and M-CSF
(A), and the association of intermediate CD14++CD16+ monocyte counts with M-CSF (B) or CRP concentrations (C) were evaluated by Spearman’s
Rank correlation test. A potential correlation between TGFβ1 and CRP levels (D) or TGFβ1 and intermediate CD14++CD16+ monocytes (E) was similarly
investigated. No correlation was found for perioperative plasma concentrations of ANG-2 and CD14++TIE2+ TEMs (F).
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obstruction syndrome, while 12 patients (32%) were classi-
fied as NASH (non-alcoholic steatohepatitis) or CASH
(chemotherapy-associated steatohepatitis). No difference
was found in liver function parameters or intermediate
monocytes of POD 3–4 between patients with and without
steatohepatitis (Additional file 3).Figure 6 Correlations between liver function parameters and the inte
(C) ALAT and (D) LDH as determined by routine hospital analysis on post-o
CD14++CD16+ monocytes on POD 3 by Spearman’s Rank correlation test.Discussion
This study demonstrates that liver resection triggers a
strong shift in monocyte subsets and monocyte regulating
cytokines. Elevated numbers of the reportedly pro-
angiogenic CD16+ intermediate population and decreased
numbers of CD16- classical monocytes were detected in
patient blood on POD 1 and 3. This rapid increase inrmediate monocyte subset. (A) Blood levels of bilirubin, (B) ASAT,
perative days 3–4 were compared to the frequency of intermediate
























*Scoring system according to Kleiner et al. [27].
CASH: chemotherapy-associated steatohepatitis, NASH: non-alcoholic
steatohepatitis, ND: not determined, SOS: sinusoidal obstruction syndrome.
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ate monocytes in subhepatic wound fluid by POD 3. Com-
parably, M-CSF, TGFβ1, CRP and ANG-2 increased in
patient plasma after surgery; in particular M-CSF and CRP
concentrations correlated strongly with the level of inter-
mediate monocytes.
Surgical tissue damage leads to an acute phase re-
sponse in the liver and hence an increase in CRP release
into the blood [28]. Since CRP is known to induce
M-CSF expression by endothelial cells [14] and M-CSF
up-regulates CD16 expression on human monocytes [8],
the observed changes in monocyte phenotype are likely
to be triggered as a result of the altered cytokine milieu
after surgery. In this regard our findings are in line with
a recently published study showing increased values and
a correlation of intermediate monocytes, M-CSF and
CRP in trauma patients [29].
We would like to note that our study was focused on
the analysis of the potentially pro-angiogenic population
of CD16+ intermediate monocytes as opposed to the
majority of CD16- classical monocytes. With respect to
the third subset of CD16++ non-classical monocytes,
our detection method was prone to “contamination”with overlapping natural killer cells in flow cytometric
measurements [30]. Hence, we generally omitted this
subset from our analysis. However, to gain preliminary
information whether non-classical monocytes were simi-
larly induced by liver surgery, we devised a modified
gating strategy for non-classical monocytes (Additional
file 4A): A logarithmic leukocyte density plot was intro-
duced to improve resolution of monocytes, lymphocytes
and granulocytes based on light scatter properties. Set-
ting a tight gate on the monocyte population enabled
us to minimize “contamination” of non-classical mono-
cytes by CD16++ natural killer cells or granulocytes.
We found that in contrast to the CD14++CD16+ inter-
mediate monocytes (Additional file 4C), the CD16 positive
non-classical (CD14+CD16++) subset exhibited a signifi-
cant decrease (Additional file 4D) on POD 1 (p < 0.001,
N = 24) and a partial recovery by POD 3 (p < 0.001,
N = 21). In wound fluid, the subset of non-classical mono-
cytes was essentially absent (data not shown). Thus, the
intermediate monocyte population was selectively induced
upon liver surgery which may relate to its reported angio-
genic capacity and a pertaining potential to promote liver
regeneration. While this study has focused on patients
with liver resection, a comparable rise in intermediate
monocytes to support tissue regeneration might also be
envisaged for patients undergoing major surgery other
than liver resection. This has, however, not been addressed
in the current study.
With respect to the proposed pro-angiogenic TEM sub-
set, there were no substantial fluctuations in the circulat-
ing numbers of TEMs after surgery and no correlation
with the post-operative release of ANG-2 in patient blood.
However, we found an accumulation of TIE2 positive
monocytes (CD14++TIE2+ cells) in subhepatic wound
fluid which is likely to be conditioned by the regenerating
liver. Comparably, our results are in line with preclinical
studies which detected TIE2+ monocytes in angiogenic
mouse tissue [24]. Rather than the induction of TEMs in
blood, the local upregulation of TIE2 expression on mono-
cytes due to environmental factors of the injured tissue
might be responsible for this observation. Given the role
of TIE2 in angiogenesis, the elevated expression of TIE2
on monocytes would be expected to enhance their angio-
genic properties. It has to be noted that this study was de-
signed to unravel monocyte changes and correlations in
clinical parameters but did not include functional tests.
Hence, the attribution of intermediate monocytes and
TEMs as pro-angiogenic subsets relies on the assessment
of previous reports [9,20,25].
We further addressed the question whether alterations
in the monocyte profile after liver resection are associ-
ated with hallmarks of liver injury and regeneration.
Therefore, we included liver function parameters from
routine hospital evaluation in our analysis. We found
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POD 3 with liver parameters on POD 3–4, whereas
measurements from POD 1 did not show significant cor-
relations. While the surge of intermediate monocytes on
the first post-operative day is likely an immediate reac-
tion common to all patients, a sustained increase on
POD 3 may indeed reflect a delayed, ongoing liver re-
generation and reduced organ function as indicated by
the elevated levels of liver enzymes on POD 3–4. In line,
the median blood levels of angiogenic monocytes on
POD 3 tended to be higher in patients with major (17%
intermediate subset within CD14++ monocytes) as op-
posed to minor (8%) surgery (p = 0.065, N = 21), and
intermediate monocytes significantly correlated with the
level of tissue destruction as evidenced by LDH release.
These observations strengthen our conclusion that
monocyte populations with proposed angiogenic proper-
ties are associated with the process of liver regeneration
after surgery. With respect to clinical implications the
selective induction of this monocyte subset might there-
fore be envisioned as a therapeutic approach which
merits further investigation: Bearing in mind that post-
operative monocyte counts are predictive for overall sur-
vival after resection of colorectal liver metastases [7], it
has previously been attempted to raise monocyte counts
by the perioperative treatment with recombinant GM-
CSF [31]. While GM-CSF is known to boost the immu-
noreactive properties of monocytes [31], it induces the
classical rather than the intermediate (CD16+) pheno-
type [32]. Thus, the short-term perioperative application
of M-CSF as opposed to GM-CSF might be more effect-
ive in promoting liver regeneration after surgery by se-
lectively enhancing the angiogenic monocyte subsets.
Further support to this notion was given by an experi-
mental model of partial hepatectomy in M-CSF deficient
mice, where perioperative application of recombinant
M-CSF was found to rescue liver regeneration [11].
Conclusions
In summary, our study provides novel insight into the se-
lective induction of reportedly pro-angiogenic monocyte
subsets and regulatory cytokines in response to liver resec-
tion; it is the first investigation showing an accumulation of
intermediate monocytes and TEMs close to the site of liver
regeneration after hepatectomy in a clinical setting. The
correlation between these monocyte subsets and liver pa-
rameters may indicate a functional link in liver regeneration
which warrants further investigation as therapeutic target.
Additional files
Additional file 1: Gating strategy for the detection of monocyte
subpopulations by flow cytometry. (A) Leukocytes (P1) were detected
in a forward (FS) and side scatter (SS) diagram which comprisedlymphocyte (L), monocyte (M) and granulocyte (G) populations.
(B) CD14-FITC and CD16-PC5 positive cells were then identified
among leukocytes. Classical monocytes (CD14++CD16-, gate P2) and
intermediate monocytes (CD14++CD16+, gate P3) were defined by
their high level of CD14 expression and further discriminated by the
presence or absence of CD16 surface marker. Total CD14++ monocyte
counts were deduced by combining the measurements of classical
CD14++CD16- and intermediate CD14++CD16+ monocytes. (C) TIE2
expression (black line) was determined within the total CD14++
monocyte population to detect TEMs (CD14++TIE2+, gate P4) in
reference to immunolabelling with mouse IgG1-PE isotype control
(grey line). Please note that non-classical monocytes (CD14+CD16++)
partially overlap with the CD14-CD16++ natural killer (NK) cell subset
in their marker profile and were therefore excluded from the analysis.
Additional file 2: Distribution of monocyte subsets in patients prior
to surgery as compared to healthy controls. Monocyte subsets were
determined by flow cytometry in blood samples retrieved from healthy
individuals and patients immediately prior to resection of colorectal liver
metastases. The frequency of total CD14++ monocytes (A) as well as
the distribution of classical CD14++CD16- monocytes (B), intermediate
CD14++CD16+ monocytes (C), and CD14++TIE2+ TEMs (D) were assessed.
Additional file 3: Liver function parameters and intermediate
monocytes do not differ between patients with and without
NASH or CASH. (A) Blood levels of bilirubin, (B) ASAT, (C) ALAT and
(D) the frequency of intermediate monocytes on post-operative days
3–4 were compared between patients with and without (w/o) NASH
or CASH as diagnosed by histopathology of resected liver tissue.
Additional file 4: Modified gating strategy for perioperative
monitoring of non-classical monocytes. (A) A logarithmic leukocyte
density plot was introduced to improve resolution of monocytes (M1),
lymphocytes (L) and granulocytes (G) based on forward (FS) and side
scatter (SS). Setting a tight gate (M1) on the monocyte population
enabled us to minimize “contamination” of non-classical monocytes
by CD16++ natural killer cells or granulocytes. Classical monocytes
(CD14++CD16-, gate M2), intermediate monocytes (CD14++CD16+,
gate M3) and non-classical monocytes (CD14+CD16++, gate M4) were
then discriminated by their level of CD14 and CD16 expression. The
distribution of classical (B), intermediate (C), and non-classical (D) subsets
within monocytes was evaluated prior to surgery (Pre-OP) and on
post-operative days 1 (POD 1) and 3 (POD 3).Abbreviations
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